Clinical Trial Update: MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating MCS for lower urinary tract symptoms associated with benign prostatic hyperplasia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• MCS®

Snippet

Sponsor: Health Ever Bio-Tech Co., Ltd. | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: TERMINATED